Cite
APA Citation
Zhao, Z., Li, J., Ye, R., Wu, X., Gao, L., & Niu, B. (2017). a phase II clinical study of combining FOLFIRI and bevacizumab plus erlotinib in 2nd-line chemotherapy for patients with metastatic colorectal cancer. Medicine, 96(30), . http://access.bl.uk/ark:/81055/vdc_100049352461.0x000031